Journal of Diabetes Investigation, Volume 16, Issue 7, Page 1143-1146, July 2025.
wiley +1 more source
Prospective evaluation of soluble CD14 as a biomarker following five aflibercept treatments in diabetic macular edema. [PDF]
Lee H+6 more
europepmc +1 more source
Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab [PDF]
Roomasa Channa+6 more
openalex +1 more source
Study of the efficacy and the mechanism of action of lanreotide for the treatment of persistent diabetic macular edema. [PDF]
Fernandez-Lopez E+6 more
europepmc +1 more source
Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results [PDF]
Katharina Kriechbaum+7 more
openalex +1 more source
Molecular-Genetic Biomarkers of Diabetic Macular Edema. [PDF]
Andrés-Blasco I+5 more
europepmc +1 more source
Soluble Mediators of Diabetic Macular Edema: The Diagnostic Role of Aqueous VEGF and Cytokine Levels in Diabetic Macular Edema [PDF]
Leah A. Owen, M. Elizabeth Hartnett
openalex +1 more source
Diabetic Macular Edema in the Western Part of Romania: Screening to Improve Patient Outcomes. [PDF]
Ivanescu A+4 more
europepmc +1 more source
The Evolving Treatment Options for Diabetic Macular Edema [PDF]
Atul Jain, Neeta Varshney, Colin Smith
openalex +1 more source